Unas olas de calor que ponen a la vida en peligro serán comunes en 2100
VIERNES, 26 de agosto de 2022 (HealthDay News) — Unas olas de calor potencialmente letales serán más comunes a finales de este siglo, según un nuevo estudio.Un “índice de calor” peligroso, la sensación de la temperatura cuando se combinan la humedad …
Learn MoreMuy pocas ciudades de EE. UU. cuentan con buenos planes de evacuación en caso de huracán
VIERNES, 26 de agosto de 2022 (HealthDay News) — La temporada de huracanes de este año ha sido tranquila, hasta ahora, pero si se activa, o en caso de que lo haga, muchas ciudades estadounidenses no estarán preparadas para implementar evacuaciones ma…
Learn MoreWide Variance Seen in Booster Uptake Among Vaccinated U.S. Adults
MONDAY, Aug. 29, 2022 (HealthDay News) — There is considerable variation in uptake of COVID-19 boosters by geography, sociodemographic characteristics, and occupation, according to a study published online Aug. 19 in JAMA Network Open.
Israel T. …
Learn MoreBiden Administration Will Stop Sending Out Free COVID Tests on Friday
MONDAY, Aug. 29, 2022 (HealthDay News) — The days of getting free COVID-19 tests by mail are drawing to a close.The Biden administration plans to stop sending test kits to Americans on Sept. 2 in order to reserve remaining tests for a fall surge. Lac…
Learn MoreBlack Men Less Likely to Get Monkeypox Vaccine
MONDAY, Aug. 29, 2022 (HealthDay News) — Although there’s now enough monkeypox vaccine to go around, the Americans who need it most still may not be getting it, a new report shows.Only 10% of the Jynneos vaccine doses have been given to Black people,…
Learn MoreHypertension in Pregnancy Is Getting More Common for Gen Z Women
MONDAY, Aug. 29, 2022 (HealthDay News) — Gen Zers and millennials are about twice as likely to develop high blood pressure during pregnancy than women from the baby boom generation were, a new study finds. This includes conditions such as preeclampsi…
Learn MoreFDA Approves Imbruvica for Pediatric Chronic Graft Versus Host Disease
FRIDAY, Aug. 26, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for pediatric patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy.
The ap…
Learn MoreUn nuevo tratamiento para la EM se muestra promisorio en un ensayo
JUEVES, 25 de agosto de 2022 (HealthDay News) — Una terapia experimental de anticuerpos para la esclerosis múltiple (EM) puede reducir las exacerbaciones de síntomas a la mitad, en comparación con el tratamiento estándar, encontró un nuevo ensayo clí…
Learn MoreLos casos de viruela del simio quizá por fin estén bajando, y se observan reducciones en Europa, según la OMS
JUEVES, 25 de agosto de 2022 (HealthDay News) — El número de casos de viruela del simio alrededor del mundo se redujo en un 21 por ciento la semana pasada, anunció el jueves la Organización Mundial de la Salud (OMS).Esta significativa reducción podrí…
Learn MoreUp to 4 Million Americans Out of Work With Long COVID
FRIDAY, Aug. 26, 2022 (HealthDay News) — In yet another example of the financial toll that the new coronavirus has exacted during the pandemic, a new report estimates that up to 4 million Americans are out of work as they struggle with long COVID.”T…
Learn More